MALVERN, Pa., May 16, 2022 /PRNewswire/ -- Reaction Biology ("Reaction" or the "Company"), an industry- leading provider of drug discovery services, today announced the expansion of its Executive ...
MALVERN, Pa., Dec. 19, 2022 /PRNewswire/ -- Reaction Biology Corporation ("Reaction"), an industry-leading provider of drug discovery services, today announced that it has been selected to participate ...
MALVERN, Pa., Dec. 2, 2022 /PRNewswire/ -- Reaction Biology Corporation ("Reaction"), an industry-leading provider of drug discovery and development services, today announced that the Company has ...
MALVERN, Pa., April 3, 2024 /PRNewswire/ -- Reaction Biology ("Reaction" or the "Company"), an industry-leading provider of drug discovery and development services, today announced that it will ...
MALVERN, Pa., March 16, 2022 /PRNewswire/ -- Reaction Biology ("Reaction" or the "Company"), an industry- leading provider of drug discovery services, today announced the closing of a significant ...